342 related articles for article (PubMed ID: 25016364)
21. Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats.
Yang K; Wang Y; Ding Y; Cui H; Zhou D; Chen L; Ma Z; Wang W; Zhang W; Luan J
Chronobiol Int; 2019 Aug; 36(8):1058-1071. PubMed ID: 31096810
[No Abstract] [Full Text] [Related]
22. Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double-blind, 8-week study.
Huo Y; Li W; Webb R; Zhao L; Wang Q; Guo W
J Clin Hypertens (Greenwich); 2019 Jan; 21(1):67-76. PubMed ID: 30536595
[TBL] [Abstract][Full Text] [Related]
23. Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: high-dose ARB with ACE inhibitor (Hawaii) study.
Ohishi M; Takeya Y; Tatara Y; Yamamoto K; Onishi M; Maekawa Y; Kamide K; Rakugi H
Hypertens Res; 2010 Nov; 33(11):1150-4. PubMed ID: 20703230
[TBL] [Abstract][Full Text] [Related]
24. Effects of valsartan and hydrochlorothiazide alone and in combination on blood pressure and heart rate in conscious-telemetered spontaneously hypertensive rats (SHR).
Webb RL; Navarrete AE; Davis S
Am J Hypertens; 1998 Jan; 11(1 Pt 1):59-65. PubMed ID: 9504451
[TBL] [Abstract][Full Text] [Related]
25. Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nomega-nitro-L-arginine methyl ester-treated spontaneously hypertensive rats.
de Gasparo M; Hess P; Clozel M; Persohn E; Roman D; Germann PG; Clozel JP; Webb RL
J Cardiovasc Pharmacol; 2002 Nov; 40(5):789-800. PubMed ID: 12409988
[TBL] [Abstract][Full Text] [Related]
26. Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats.
Takai S; Jin D; Aritomi S; Niinuma K; Miyazaki M
Hypertens Res; 2013 Apr; 36(4):342-8. PubMed ID: 23190689
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 2nd communication: valsartan prevents end-organ damage in spontaneously hypertensive stroke-prone rats during 1-year treatment.
Kometani M; Hayashi N; Yamamoto S; Nakao K; Inukai T
Arzneimittelforschung; 1997 May; 47(5):613-9. PubMed ID: 9205774
[TBL] [Abstract][Full Text] [Related]
28. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
Ke YS; Cao H; Yang T
Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
[TBL] [Abstract][Full Text] [Related]
29. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
Galle J; Schwedhelm E; Pinnetti S; Böger RH; Wanner C;
Nephrol Dial Transplant; 2008 Oct; 23(10):3174-83. PubMed ID: 18450829
[TBL] [Abstract][Full Text] [Related]
30. Effect of add-on aliskiren to type 1 angiotensin receptor blocker therapy on endothelial function and autonomic nervous system in hypertensive patients with ischemic heart disease.
Ozeki A; Amiya E; Watanabe M; Hosoya Y; Takata M; Watanabe A; Kawarasaki S; Nakao T; Watanabe S; Omori K; Yamada N; Tahara Y; Hirata Y; Nagai R
J Clin Hypertens (Greenwich); 2014 Aug; 16(8):591-8. PubMed ID: 25039889
[TBL] [Abstract][Full Text] [Related]
31. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
[TBL] [Abstract][Full Text] [Related]
32. Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.
Araki S; Hirooka Y; Kishi T; Yasukawa K; Utsumi H; Sunagawa K
Hypertens Res; 2009 Dec; 32(12):1091-6. PubMed ID: 19763130
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats.
Rizzoni D; Pasini E; Flati V; Rodella LF; Paiardi S; Assanelli D; De Ciuceis C; Porteri E; Boari GE; Rezzani R; Speca S; Favero G; Martinotti S; Toniato E; Platto C; Agabiti-Rosei E
J Hypertens; 2008 Aug; 26(8):1595-601. PubMed ID: 18622238
[TBL] [Abstract][Full Text] [Related]
34. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.
Gillies LK; Lu M; Wang H; Lee RM
Hypertension; 1997 Dec; 30(6):1471-8. PubMed ID: 9403569
[TBL] [Abstract][Full Text] [Related]
35. Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension.
Hirooka Y; Kimura Y; Sagara Y; Ito K; Sunagawa K
Clin Exp Hypertens; 2008 Apr; 30(3):267-76. PubMed ID: 18425706
[TBL] [Abstract][Full Text] [Related]
36. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
Harada N; Shimozawa N; Okajima K
Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690
[TBL] [Abstract][Full Text] [Related]
37. Positive influence of AT(1) receptor antagonism upon the impaired celiprolol-induced vasodilatation in aorta from spontaneously hypertensive rats.
Sauvaget F; Mallem MY; Bucas V; Gogny M; Desfontis JC; Noireaud J
Eur J Pharmacol; 2010 Oct; 644(1-3):169-75. PubMed ID: 20637193
[TBL] [Abstract][Full Text] [Related]
38. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats.
Tschudi MR; Criscione L; Novosel D; Pfeiffer K; Lüscher TF
Circulation; 1994 May; 89(5):2212-8. PubMed ID: 8181147
[TBL] [Abstract][Full Text] [Related]
39. Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans.
Coltamai L; Maillard M; Simon A; Vogt B; Burnier M
J Hypertens; 2010 Mar; 28(3):520-6. PubMed ID: 20104189
[TBL] [Abstract][Full Text] [Related]
40. Prehypertensive renin-angiotensin-aldosterone system blockade in spontaneously hypertensive rats ameliorates the loss of long-term vascular function.
Baumann M; Megens R; Bartholome R; Dolff S; van Zandvoort MA; Smits JF; Struijker-Boudier HA; De Mey JG
Hypertens Res; 2007 Sep; 30(9):853-61. PubMed ID: 18037779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
